CAH Chart

1 Month

	Date	Diff
	2025-05-05	+1.65 %
Cardinal Health (CAH) stock rose 1.65% as analysts maintain a "Moderate Buy" rating with increased price targets following stronger-than-expected earnings results that exceeded consensus estimates.
	2025-05-02	+2.75 %
Cardinal Health (CAH) stock rose by 2.75% following an upgrade by UBS Group, which increased its target price from $150.00 to $160.00 while maintaining a buy rating, along with several other analysts adjusting their price targets and ratings positively.
	2025-04-30	+1.04 %
Shares of Cardinal Health, Inc. (CAH) rose 1.04% after UBS Group raised its price target for the stock from $150.00 to $160.00, reflecting strong buy sentiment from analysts and high trading volume. The increase in stock price is attributed to positive analyst ratings and price target upgrades from multiple firms, signaling confidence in Cardinal Health’s performance and potential for future growth.
	2025-04-10	-1.2 %
Cardinal Health's stock (CAH) declined by 1.2%, despite having a consensus rating of "Moderate Buy" among analysts, potentially due to overall market fluctuations or investor sentiment, rather than specific negative news regarding the company itself.
	2025-04-04	-5.44 %
Cardinal Health (CAH) stock dropped by 5.44% following a downgrade in Q3 2025 earnings estimates by Leerink Partners, which revised the expected earnings per share down from $2.18 to $2.16.
	2025-04-02	+1.12 %
Cardinal Health's stock (CAH) rose by 1.12% after Mizuho increased its price target from $142.00 to $150.00, maintaining an outperform rating, which reflects growing analyst confidence in the company. Cardinal Health (CAH) stock rose by 1.12% following an upgrade in its price target from Mizuho, which increased from $142.00 to $150.00, indicating positive analyst sentiment towards the stock's performance.
	2025-03-13	-0.44 %
Cardinal Health's stock (CAH) decreased by 0.44% amid mixed analyst ratings and recent adjustments in price targets by major financial firms, despite an overall recommendation of "Moderate Buy" from analysts. The stock decline could be attributed to market volatility and investor sentiment despite positive earnings reports and upgrades from analysts.
	2025-03-12	+2.14 %
The article discusses the upcoming Annual General Meeting of Bavarian Nordic A/S, highlighting proposed resolutions regarding profit application, board member re-elections, and plans for share capital increase. As for Cardinal Health (CAH) stock rising by 2.14%, it is likely due to positive investor sentiment regarding the company's ongoing initiatives or financial performance, which may not be detailed in the provided text.
	2025-03-11	+0.19 %
Cardinal Health (CAH) stock rose by 0.19% after Atria Investments significantly increased its holdings in the company by 22.9%, indicating strong institutional confidence, along with other hedge funds also boosting their positions in the stock.
	2025-02-25	+0.2 %
Cardinal Health (CAH) stock rose 0.2% following an upward revision in EPS estimates for FY2025 by Zacks Research, which increased its forecast from $7.75 to $7.88 per share, indicating positive earnings expectations.
	2025-02-18	+0.03 %
Cardinal Health (CAH) stock rose by 0.03% due to positive analyst upgrades and a successful earnings report that exceeded expectations, along with increasing institutional investment interest.
	2025-02-13	-0.22 %
Cardinal Health (CAH) stock experienced a slight decline of -0.22%, attributed to broader market sentiments and mixed reactions from institutional investors, despite some positive reassessments and upgrades from research analysts on the company's performance and future prospects.
	2025-02-06	-0.31 %
Cardinal Health (CAH) stock decreased by 0.31% despite an upgrade in its price target by Wells Fargo to $136.00, reflecting mixed investor sentiment following recent earnings performance and varying ratings from multiple brokerages. The decline could be attributed to a combination of profit booking after recent gains, ongoing market volatility, or potential concerns from investors regarding the company's financial metrics despite positive earnings news.
	2025-02-03	+1.35 %
Cardinal Health (CAH) stock rose by 1.35% following the company's positive quarterly earnings report, where it surpassed analysts' expectations, along with supportive upgrades and price target increases from various investment analysts despite a slight decrease in earnings estimates for Q3 2025. Cardinal Health's stock (CAH) rose by 1.35% after Perigon Wealth Management LLC and other institutional investors increased their stakes in the company, coupled with recent positive upgrades and higher price targets from multiple equities research analysts. Cardinal Health (CAH) stock rose by 1.35% following an increase in target price upgrades from multiple analysts, reflecting positive market sentiment and overall improved ratings for the company.
	2025-01-30	+0.39 %
Cardinal Health (CAH) stock rose by 0.39% due to overall positive market sentiment and investor optimism ahead of the upcoming Union Budget 2025, which is expected to focus on boosting consumption and infrastructure spending. Cardinal Health (CAH) stock was up 0.39% amid a generally calm market as traders were optimistic about upcoming economic reports and corporate earnings, reflecting a positive sentiment regarding market stability and growth despite mixed results from major tech firms. Cardinal Health (CAH) stock saw a 0.39% increase last night, likely due to positive market sentiments surrounding upcoming economic initiatives and budget discussions aimed at boosting consumption and infrastructure spending in light of current economic conditions.
	2025-01-27	+1.47 %
Cardinal Health (CAH) stock rose 1.47% following several analysts, including JPMorgan Chase & Co. and Citigroup, raising their price targets and ratings on the stock, indicating positive market sentiment and expectations for its performance. Cardinal Health (CAH) stock rose by 1.47% due to positive financial results exceeding analyst expectations, upgrades in stock ratings from multiple research firms, and increasing institutional investment interest in the company.
	2025-01-24	-0.36 %
Cardinal Health (CAH) stock fell by 0.36% due to mixed investor sentiment, despite some large investors increasing their stakes, as the company reported declining revenues year-over-year in its last earnings report. Cardinal Health (CAH) stock fell by 0.36% due to a mix of investor activity and recent analyst ratings, including upgrades and downgrades, along with the company's quarterly earnings report showing a decline in year-over-year revenue despite an earnings beat. Cardinal Health (CAH) stock decreased by 0.36% due to a reduction in stake by Assenagon Asset Management and various changes in institutional investments, alongside mixed ratings and a recent quarterly revenue decline of 4.3% compared to the previous year. Cardinal Health (CAH) stock experienced a decline of 0.36% due to a combination of factors, including a mixed investor sentiment following recent changes in rating from analysts and a slight dip in year-over-year quarterly revenue despite beating earnings expectations.
	2025-01-23	+0.43 %
Cardinal Health (CAH) stock rose 0.43% as UMB Bank n.a. increased its stake in the company by 6.8%, reflecting growing institutional interest and positive analyst upgrades that boosted investor confidence.
	2025-01-22	+0.72 %
The article discusses concerns from activist investor Ananym Capital Management regarding the need for CEO succession planning at Henry Schein, as they plan to nominate directors to push for cost-cutting and better capital allocation, amidst worries from investors about the company's leadership stability. Cardinal Health (CAH) stock may have gone up by 0.72% due to related market movements and positive investor sentiment influenced by discussions surrounding corporate governance and expectations for improved financial strategies at competitors like Henry Schein. Cardinal Health (CAH) stock rose 0.72% last night, likely due to positive institutional investment activity, including raised target prices and ratings upgrades from several research analysts, indicating strong market confidence in the company's future performance.
	2025-01-17	-0.6 %
Cardinal Health (CAH) stock fell by 0.6% amid mixed investor activity and despite beating earnings expectations, as the market weighed its quarterly revenue decline and a recent dividend payout. The decline in stock price could be attributed to concerns about the 4.3% decrease in quarterly revenue compared to the same period last year, which may have affected investor sentiment despite the positive earnings report. The Cardinal Health (CAH) stock saw a decline of 0.6%, which is attributed to increasing safety concerns and a market shift towards phenol-free thermal paper, impacting its traditional procurement practices, particularly in the healthcare supply sector.
	2025-01-16	+1.86 %
Cardinal Health (CAH) stock rose by 1.86% due in part to increasing interest from large institutional investors, upgrades from multiple analysts with higher price targets and "buy" ratings, and a strong quarterly earnings report that exceeded expectations despite a revenue decline. Cardinal Health (CAH) stock experienced a 1.86% increase, attributed to increased institutional investments, positive earnings reports that beat expectations, and upgraded ratings from several equity research analysts which boosted investor confidence.
	2025-01-15	+0.55 %
Cardinal Health's (CAH) stock rose by 0.55% due to positive analyst upgrades, including Bank of America's upgrade from "neutral" to "buy" with a higher price target, as well as strong quarterly earnings that exceeded expectations. Cardinal Health (CAH) stock rose 0.55% largely due to increased institutional investments, positive upgrades from multiple research analysts, and a strong quarterly earnings report that exceeded expectations.
	2025-01-10	-0.78 %
Cardinal Health's (CAH) stock decreased by 0.78% despite receiving a buy rating upgrade from TD Cowen, primarily due to overall market fluctuations and the company's reported quarterly revenue decline of 4.3% compared to the same quarter last year.
	2025-01-07	+1.48 %
Cardinal Health (CAH) stock rose 1.48% following positive analyst reviews that upgraded ratings and target prices, alongside better-than-expected earnings and revenue reported in its last earnings results. Cardinal Health's stock (CAH) rose 1.48% following an upgrade from Bank of America from a neutral to a buy rating, along with several other analysts revising their ratings and price targets upward due to strong quarterly earnings that exceeded expectations.
	2025-01-06	+0.28 %
Cardinal Health (CAH) stock saw a 0.28% increase due to positive movements in institutional investments, including CWA Asset Management Group increasing its holdings by 10.1%, along with favorable analyst reports enhancing market confidence in the company. Cardinal Health, Inc. (CAH) stock rose by 0.28% due to increased investments from major hedge funds and favorable analyst ratings, which boosted investor confidence in the company's performance and future prospects. Cardinal Health (CAH) stock rose by 0.28% following an upgrade by analysts at Bank of America from a neutral to a buy rating, with the price target increased from $132.00 to $145.00.
	2024-12-31	+0.3 %
Cardinal Health (CAH) stock rose 0.3% as the company announced a quarterly dividend, reflecting its consistent dividend growth and positive earnings performance, which reassures investors about financial stability and future profitability.
	2024-12-17	-0.63 %
Cardinal Health (CAH) stock decreased by 0.63% due to ongoing shortages of essential medical supplies for home-care patients in Ontario, following a problematic change in the distribution system that has resulted in delays, incomplete shipments, and declining quality of medical products.
	2024-12-12	+0.03 %
Cardinal Health (CAH) stock experienced a slight increase of 0.03% last night, attributed to the company's strong growth potential in the expanding healthcare sector, positive value and growth ratings from AAII's A+ Stock Grades, and the overall optimistic outlook for healthcare spending and technological advancements like AI.
	2024-12-10	-0.95 %
Cardinal Health (CAH) stock decreased by 0.95% amidst mixed analyst sentiments, with raised earnings estimates conflicting with a reported decline in quarterly revenue and ongoing concerns about net margins and return on equity. The stock likely went down due to investor reactions to the company's quarterly earnings report, which showed lower revenue than the previous year, even though earnings per share exceeded estimates.
	2024-12-06	-0.07 %
Cardinal Health (CAH) stock fell 0.07% amid a trend of mixed institutional investment activity, including Townsquare Capital LLC reducing its stake by 10.2% in the 3rd quarter, which may reflect wavering confidence in the stock's performance despite recent earnings beating estimates. Cardinal Health, Inc. (CAH) stock experienced a slight decline of 0.07% following its latest earnings report, where despite beating earnings expectations, the company's revenue was down 4.3% year-over-year, possibly leading to investor concerns impacting stock performance.
	2024-12-02	+0.19 %
Cardinal Health (CAH) stock rose 0.19% following significant institutional investments and favorable analyst price target upgrades, indicating positive market sentiment and company performance.
	2024-11-29	-0.32 %
Cardinal Health (NYSE: CAH) experienced a 0.32% decline in stock price, attributed to mixed reactions from institutional investors and analysts, despite recent increases in target prices following the company's stronger-than-expected earnings report.
	2024-11-25	-0.06 %
Cardinal Health (CAH) stock fell by 0.06% last night, likely due to mixed analyst ratings and a decrease in year-over-year revenue, despite positive quarterly earnings surpassing estimates.
	2024-11-19	-1.42 %
Cardinal Health (CAH) stock fell by 1.42% following the release of a quarterly earnings report that, despite beating expectations with $1.88 EPS and $52.28 billion in revenue, indicated a 4.3% decline in year-over-year revenue, highlighting potential concerns about future performance.
	2024-11-13	+1.47 %
Cardinal Health, Inc. (CAH) stock rose by 1.47% due to positive earnings results that exceeded analysts' expectations, favorable updates from several research firms increasing their price targets, and a generally optimistic sentiment among institutional investors regarding the company's prospects. Cardinal Health (CAH) stock rose 1.47% after Sigma Planning Corp and other large investors increased their positions in the company, signaling positive investor sentiment and confidence in its financial performance, which includes beating earnings estimates and announcing a quarterly dividend. Cardinal Health (CAH) stock rose 1.47% following a strong institutional investment sentiment, highlighted by Assetmark Inc.’s increase in its stake by 25.8% and positive earnings reports that outperformed market expectations. Cardinal Health (CAH) stock rose by 1.47% following its announcement to acquire Advanced Diabetes Supply Group, which is expected to enhance its market position in the diabetes supplies sector.
	2024-11-08	+1.98 %
Cardinal Health (CAH) stock rose by 1.98% due to a combination of positive earnings results that beat analysts' expectations, upgraded price targets from several analysts, and ongoing institutional investment interest despite some hedge funds reducing their holdings.
	2024-11-06	+2.12 %
Cardinal Health (CAH) stock rose 2.12% following positive earnings results that exceeded analyst expectations and an increase in price targets from multiple brokerage firms, indicating strong investor confidence. Cardinal Health (CAH) stock rose by 2.12% following the announcement of raised price targets from several brokerages, including Deutsche Bank's increase from $119.00 to $124.00, signaling optimism about the company's performance despite a mixed earnings report. Cardinal Health (CAH) stock rose by 2.12% following investment analysts at Mizuho raising its price target from $110.00 to $120.00, indicating potential upside, along with positive earnings results that exceeded expectations. Cardinal Health's stock (CAH) rose by 2.12% after positive quarterly earnings, where it beat analysts’ expectations, coupled with several analysts raising their price targets, indicating favorable investor sentiment and confidence in the company's performance. Cardinal Health (CAH) stock rose 2.12% after Barclays raised its price target from $117.00 to $133.00, indicating substantial upside potential, along with positive earnings results that exceeded analysts' expectations.